Related Experiment Video
Updated: Jul 30, 2025

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Guidelines on the classification of foot ulcers in people with diabetes (IWGDF 2023 update)
Matilde Monteiro-Soares1,2,3, Emma J Hamilton4,5, David A Russell6,7
1Portuguese Red Cross School of Health-Lisbon, Lisbon, Portugal.
Insights
This update to the Diabetic Foot guidelines recommends the SINBAD and WIfI classification systems for diabetic foot ulcers in clinical practice. These systems aid communication and risk stratification for better patient outcomes.
Area of Science:
- Podiatry
- Diabetology
- Clinical Practice Guidelines
Background:
- Scheduled update of the 2019 International Working Group of the Diabetic Foot (IWGDF) guidelines.
- Focuses on classification systems for diabetic foot ulcers in routine clinical practice.
- Based on systematic literature review and expert opinion using GRADE methodology.
Purpose of the Study:
- To update recommendations on classification systems for diabetic foot ulcers.
- To identify usable, accurate, and reliable systems for predicting complications and resource use.
- To determine appropriate systems for specific clinical scenarios.
Main Methods:
- Systematic review of 149 articles identifying 28 classification systems.
- Evaluation of systems for usability, accuracy, and reliability.
- Group debate and consensus to determine system applicability for specific clinical scenarios.
Main Results:
- Recommends SINBAD (Site, Ischaemia, Bacterial infection, Area and Depth) or WIfI (Wound, Ischaemia, foot Infection) for healthcare professional communication.
- No system recommended for predicting individual ulcer outcomes.
- IDSA/IWGDF or WIfI recommended for characterising infected ulcers.
- WIfI recommended for characterising peripheral artery disease and stratifying risk.
- SINBAD score recommended for auditing population outcomes.
Conclusions:
- Recommendations provide clinical utility despite low certainty of evidence.
- The proposed classifications aim to improve the management of diabetic foot ulcers.
- Emphasizes the description of individual variables over total scores for SINBAD and WIfI.
Background:
This publication represents a scheduled update of the 2019 guidelines of the International Working Group of the Diabetic Foot (IWGDF) addressing the use of systems to classify foot ulcers in people with diabetes in routine clinical practice. The guidelines are based on a systematic review of the available literature that identified 28 classifications addressed in 149 articles and, subsequently, expert opinion using the GRADE methodology.
Methods:
First, we have developed a list of classification systems considered as being potentially adequate for use in a clinical setting, through the summary of judgements for diagnostic tests, focussing on the usability, accuracy and reliability of each system to predict ulcer-related complications as well as use of resources. Second, we have determined, following group debate and consensus, which of them should be used in specific clinical scenarios. Following this process, in a person with diabetes and a foot ulcer we recommend: (a) for communication among healthcare professionals: to use the SINBAD (Site, Ischaemia, Bacterial infection, Area and Depth) system (first option) or consider using WIfI (Wound, Ischaemia, foot Infection) system (alternative option, when the required equipment and level of expertise is available and it is considered feasible) and in each case the individual variables that compose the systems should be described rather than a total score; (b) for predicting the outcome of an ulcer in a specific individual: no existing system could be recommended; (c) for characterising a person with an infected ulcer: the use of the IDSA/IWGDF classification (first option) or consider using the WIfI system (alternative option, when the required equipment and level of expertise is available and it is considered as feasible); (d) for characterising a person with peripheral artery disease: consider using the WIfI system as a means to stratify healing likelihood and amputation risk; (e) for the audit of outcome(s) of populations: the use of the SINBAD score.
Conclusions:
For all recommendations made using GRADE, the certainty of evidence was judged, at best, as being low. Nevertheless, based on the rational application of current data this approach allowed the proposal of recommendations, which are likely to have clinical utility.
Related Concept Videos
Peripheral Artery Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetes: Symptoms, Diagnosis, and Complications
Traditional Level Of Health Care System
The preventive healthcare service includes tests for screening. Preventive health care services include identifying and reducing disease risk...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

